vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and FRANKLIN STREET PROPERTIES CORP (FSP). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $26.0M, roughly 1.7× FRANKLIN STREET PROPERTIES CORP). AbCellera Biologics Inc. runs the higher net margin — -19.9% vs -28.1%, a 8.2% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -8.2%). FRANKLIN STREET PROPERTIES CORP produced more free cash flow last quarter ($-12.7M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -8.7%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Franklin Street Properties Corp is a Massachusetts-based real estate investment trust (REIT) in the United States. It primarily invests in, owns, and operates high-quality office properties across major U.S. metropolitan markets, serving corporate tenants across various industry segments, and delivers stable long-term returns via rental income and strategic asset management.
ABCL vs FSP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $26.0M |
| Net Profit | $-8.9M | $-7.3M |
| Gross Margin | — | 59.4% |
| Operating Margin | -63.7% | -27.9% |
| Net Margin | -19.9% | -28.1% |
| Revenue YoY | 788.4% | -8.2% |
| Net Profit YoY | 73.9% | 14.1% |
| EPS (diluted) | $-0.03 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $26.0M | ||
| Q3 25 | $9.0M | $27.3M | ||
| Q2 25 | $17.1M | $26.7M | ||
| Q1 25 | $4.2M | $27.1M | ||
| Q4 24 | $5.0M | $28.4M | ||
| Q3 24 | $6.5M | $29.7M | ||
| Q2 24 | $7.3M | $30.8M | ||
| Q1 24 | $10.0M | $31.2M |
| Q4 25 | $-8.9M | $-7.3M | ||
| Q3 25 | $-57.1M | $-8.3M | ||
| Q2 25 | $-34.7M | $-7.9M | ||
| Q1 25 | $-45.6M | $-21.4M | ||
| Q4 24 | — | $-8.5M | ||
| Q3 24 | $-51.1M | $-15.6M | ||
| Q2 24 | $-36.9M | $-21.0M | ||
| Q1 24 | $-40.6M | $-7.6M |
| Q4 25 | — | 59.4% | ||
| Q3 25 | — | 60.9% | ||
| Q2 25 | — | 59.9% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 59.7% | ||
| Q3 24 | — | 61.0% | ||
| Q2 24 | — | 64.2% | ||
| Q1 24 | — | 64.7% |
| Q4 25 | -63.7% | -27.9% | ||
| Q3 25 | -851.8% | -30.5% | ||
| Q2 25 | -290.2% | -29.2% | ||
| Q1 25 | -1479.6% | -78.9% | ||
| Q4 24 | — | -29.9% | ||
| Q3 24 | -1439.4% | -52.4% | ||
| Q2 24 | -1276.2% | -68.0% | ||
| Q1 24 | -551.5% | -24.0% |
| Q4 25 | -19.9% | -28.1% | ||
| Q3 25 | -637.8% | -30.5% | ||
| Q2 25 | -203.3% | -29.5% | ||
| Q1 25 | -1077.2% | -79.1% | ||
| Q4 24 | — | -30.0% | ||
| Q3 24 | -785.4% | -52.6% | ||
| Q2 24 | -504.3% | -68.2% | ||
| Q1 24 | -408.0% | -24.2% |
| Q4 25 | $-0.03 | $-0.06 | ||
| Q3 25 | $-0.19 | $-0.08 | ||
| Q2 25 | $-0.12 | $-0.08 | ||
| Q1 25 | $-0.15 | $-0.21 | ||
| Q4 24 | — | $-0.09 | ||
| Q3 24 | $-0.17 | $-0.15 | ||
| Q2 24 | $-0.13 | $-0.20 | ||
| Q1 24 | $-0.14 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $30.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $607.0M |
| Total Assets | $1.4B | $892.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $30.6M | ||
| Q3 25 | $83.2M | $31.4M | ||
| Q2 25 | $92.4M | $29.4M | ||
| Q1 25 | $159.3M | $30.2M | ||
| Q4 24 | $156.3M | $41.1M | ||
| Q3 24 | $126.6M | $40.9M | ||
| Q2 24 | $148.3M | $30.2M | ||
| Q1 24 | $123.6M | $34.2M |
| Q4 25 | $966.9M | $607.0M | ||
| Q3 25 | $964.0M | $615.3M | ||
| Q2 25 | $1.0B | $624.7M | ||
| Q1 25 | $1.0B | $633.4M | ||
| Q4 24 | $1.1B | $655.9M | ||
| Q3 24 | $1.1B | $665.4M | ||
| Q2 24 | $1.1B | $682.1M | ||
| Q1 24 | $1.1B | $703.9M |
| Q4 25 | $1.4B | $892.9M | ||
| Q3 25 | $1.4B | $901.0M | ||
| Q2 25 | $1.4B | $903.2M | ||
| Q1 25 | $1.3B | $916.4M | ||
| Q4 24 | $1.4B | $946.9M | ||
| Q3 24 | $1.4B | $981.5M | ||
| Q2 24 | $1.4B | $1.0B | ||
| Q1 24 | $1.5B | $1.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $3.8M |
| Free Cash FlowOCF − Capex | $-44.6M | $-12.7M |
| FCF MarginFCF / Revenue | -99.4% | -48.6% |
| Capex IntensityCapex / Revenue | 21.9% | 63.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $-25.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $3.8M | ||
| Q3 25 | $-52.6M | $8.3M | ||
| Q2 25 | $-32.4M | $-2.9M | ||
| Q1 25 | $-11.6M | $-5.5M | ||
| Q4 24 | $-108.6M | $9.0M | ||
| Q3 24 | $-28.9M | $14.5M | ||
| Q2 24 | $-30.0M | $-648.0K | ||
| Q1 24 | $-41.7M | $-7.1M |
| Q4 25 | $-44.6M | $-12.7M | ||
| Q3 25 | $-61.5M | $3.0M | ||
| Q2 25 | $-45.8M | $-5.7M | ||
| Q1 25 | $-22.2M | $-9.9M | ||
| Q4 24 | $-187.0M | $-16.2M | ||
| Q3 24 | $-47.4M | $8.6M | ||
| Q2 24 | $-50.1M | $-5.1M | ||
| Q1 24 | $-65.8M | $-15.8M |
| Q4 25 | -99.4% | -48.6% | ||
| Q3 25 | -687.0% | 11.0% | ||
| Q2 25 | -267.9% | -21.5% | ||
| Q1 25 | -524.0% | -36.7% | ||
| Q4 24 | -3702.8% | -57.2% | ||
| Q3 24 | -728.4% | 29.1% | ||
| Q2 24 | -683.8% | -16.7% | ||
| Q1 24 | -661.5% | -50.8% |
| Q4 25 | 21.9% | 63.0% | ||
| Q3 25 | 99.7% | 19.4% | ||
| Q2 25 | 78.2% | 10.7% | ||
| Q1 25 | 251.1% | 16.4% | ||
| Q4 24 | 1552.7% | 88.9% | ||
| Q3 24 | 284.6% | 19.6% | ||
| Q2 24 | 274.6% | 14.6% | ||
| Q1 24 | 242.5% | 28.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
